MYC and breast carcinoma: Tumors derived from this model are projected to be of the basal and luminal B subtype, according to transcriptome analysis, which implies that c-Myc overexpression might be helpful in the in vivo research of both breast cancer subtypes (Pfefferle et al., 2013[56]).